Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
IMUX similar filings
- 9 Feb 23 Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need
- 19 Jan 23 Departure of Directors or Certain Officers
- 30 Dec 22 Entry into a Material Definitive Agreement
- 17 Nov 22 Other Events
- 3 Nov 22 Immunic, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
- 20 Oct 22 Immunic Reports Pre-Planned Phase 1b Interim Analysis of IMU-935 in Psoriasis Patients Confounded by High Placebo Rate
- 11 Oct 22 Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing
Filing view
External links